Montorsi F. Prevalence of premature ejaculation: a global and regional perspective. J Sex Med 2005; 2: 96–102.
Melnik T, Althof S, Atallah AN, Puga ME, Glina S, Riera R. Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev 2011; 10: CD008195.
Wyllie MG, Powell JA. The role of local anaesthetics in premature ejaculation. Br J Urol Int 2012; 110: E943–E948.
Sunay D, Sunay M, Aydogmus Y, Bagbanci S, Arslan H, Karabulut A, Emir L. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol 2011; 59: 765–771.
McMahon CG, Porst H. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med 2011; 8: 2707–2725.
McCarty EJ, Dinsmore WW. Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation. Core Evid 2012; 7: 1–14.
Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004; 16: 369–381.
Osis L, Bishop JR. Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals 2010; 3: 3614–3628.
Andrews PW, Anderson Thomson J Jr, Amstadter A, Neale MC. Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front Psychol 2012; 3: 117.
Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: Results from a randomised, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009; 55: 957–968.
Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG et al. International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010; 7: 2947–2969.
Waldinger MD, Olivier B. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Investig Drugs 2004; 5: 743–747.
McMahon CG, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010; 7: 256–268.
Mondaini N, Fusco F, Cai T, Benemei S, Mirone V, Bartoletti R. Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a “Waterloo”. Urol 2013; 82: 620–624.
Salonia A, Rocchini L, Saccá A, Pellucchi F, Ferrari M, Carro UD et al. Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation. J Sex Med 2009; 6: 2868–2877.
Jern P, Piha J, Santtila P. Validation of three early ejaculation diagnostic tools: A composite measure is accurate and more adequate for diagnosis by updated diagnostic criteria. PLoS ONE 2013; 8: E77676.
Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002; 288: 1403–1409.
Mullins CD, Shaya FT, Meng F, Wang J, Harrison D. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy 2005; 25: 660–667.
Mitchell AJ, Selmes T. Why don’t patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat 2007; 13: 336–346.
McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol 2012; 4: 233–251.
Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006; 368: 929–937.
Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167.
Waldinger MD, Schweitzer DH. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. J Sex Med 2008; 5: 966–997.
Pae CU, Patkar AA. Paroxetine: current status in psychiatry. Expert Rev Neurother 2007; 7: 107–120.
Bailey JM, Dunne MP, Martin NG. Genetic and environmental influences on sexual orientation and its correlates in an Australian twin sample. J Pers Soc Psychol 2000; 78: 524–536.
Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The Premature Ejaculation Profile: Validation of self-reported outcome measures for research and practice. BJU Int 2009; 103: 358–364.